Endometrial cancer: A systematic review of HE4, REM and REM-B
M Degez, H Caillon, A Chauviré-Drouard, M Leroy… - Clinica chimica acta, 2021 - Elsevier
Introduction Endometrial cancer, one of the most frequent pelvic gynecologic cancer
worldwide, currently has no biomarker used to assess it in daily practice. Nonetheless …
worldwide, currently has no biomarker used to assess it in daily practice. Nonetheless …
Can the determination of HE4 and CA125 markers affect the treatment of patients with endometrial cancer?
A Cymbaluk-Płoska, P Gargulińska, M Bulsa… - Diagnostics, 2021 - mdpi.com
The aim of our research was to determine the use of CA125 and HE4 as prognostic factors
in patients with different clinical staging of endometrial cancer. Sixty-two patients with …
in patients with different clinical staging of endometrial cancer. Sixty-two patients with …
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
A Cymbaluk-Płoska, A Chudecka-Głaz… - OncoTargets and …, 2017 - Taylor & Francis
Introduction Endometrial cancer is the one of the most common cancers of the genital organ.
HE4 and MMP2 are both proteins whose serum levels increase in endometrial cancer. Aim …
HE4 and MMP2 are both proteins whose serum levels increase in endometrial cancer. Aim …
Predictive value of serum cytokeratin 19 level for the feasibility of conserving ovaries in endometrial cancer
J Xu, C Chen, J Xiong, H Wang, H Linghu - Frontiers in Medicine, 2021 - frontiersin.org
Objective: To determine the predictive value of cytokeratin 19 (CK19) for evaluating the
safety of ovarian preservation in patients with endometrial cancer (EC). Methods: Five …
safety of ovarian preservation in patients with endometrial cancer (EC). Methods: Five …
[PDF][PDF] The utility of CA125 and HE4 in patients suffering from endometrial cancer
N Zamani, MM Gilani… - … Journal of Women's …, 2020 - researchgate.net
Objectives: Uterine endometrial cancer (EC) is the most common female reproductive
system malignancy. There are various comments on pelvic and para-aortic …
system malignancy. There are various comments on pelvic and para-aortic …
[PDF][PDF] Garguli nska
A Cymbaluk-Płoska - gastric cancer, 2021 - ppm.pum.edu.pl
The aim of our research was to determine the use of CA125 and HE4 as prognostic factors
in patients with different clinical staging of endometrial cancer. Sixty-two patients with …
in patients with different clinical staging of endometrial cancer. Sixty-two patients with …
[HTML][HTML] Myoferlin expression and its correlation with FIGO histologic grading in early-stage endometrioid carcinoma
MH Kim, DH Song, GH Ko, JH Lee… - … of Pathology and …, 2018 - synapse.koreamed.org
Background For endometrioid carcinoma patients, International Federation of Gynecologists
and Obstetricians (FIGO) histologic grading is very important for identifying the appropriate …
and Obstetricians (FIGO) histologic grading is very important for identifying the appropriate …
Importance of preoperative knowledge of the biomarker HE4 in early-stage endometrial cancer regarding surgical management
Aim: To analyze the utility of HE4 assessment in preoperative management of patients with
early-stage endometrial cancer for stratification into low-risk and high-risk groups. Patients …
early-stage endometrial cancer for stratification into low-risk and high-risk groups. Patients …
Ⅱ 期子宫内膜癌临床处理进展.
张天宇， 王益勤， 王建六 - Journal of International Obstetrics …, 2017 - search.ebscohost.com
Ⅱ 期子宫内膜癌的发生率约占子宫内膜癌的12%, 诊断Ⅱ 期子宫内膜癌可将分段诊刮,
宫腔镜检查及影像学相结合以提高分期诊断的准确性. 目前对于Ⅱ 期子宫内膜癌术式的选择 …
宫腔镜检查及影像学相结合以提高分期诊断的准确性. 目前对于Ⅱ 期子宫内膜癌术式的选择 …
[PDF][PDF] Human Epididymis Protein-4 and Carbohydrate Antigen-125 for Diagnosis of Endometrial Carcinoma
SM Saed, R Al-Wazzan - Al-Rafidain Journal of Medical Sciences (ISSN …, 2024 - iasj.net
Background: Endometrial carcinoma (EC) is a common genital tumor that frequently causes
abnormal uterine bleeding (AUB). All gynecologists aimed to differentiate between …
abnormal uterine bleeding (AUB). All gynecologists aimed to differentiate between …